Sterimar vs Saline Sprays in Nasal Surgical Aftercare - a Blinded, Randomised Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
Patients undergoing nasal surgery commonly experience a variety of symptoms in the post-operative period including blockage, running, pain, bleeding and reduction in sense of smell. A variety of preparations are currently recommended for symptomatic relief in the post operative period. These include saline irrigations and sniffs, steam inhalations, decongestants and steroid drops. There is currently no level 1 evidence in literature to support the use of any particular preparation over others in nasal surgical aftercare. We propose to conduct a single blinded, randomised trial comparing saline sprays vs Sterimar, a commercially available aerosolised isotone saline solution, comparing patients' symptom scores following septal surgery. The trial will help to establish efficacy and symptom control and advantages of one solution and delivery device over the other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Feb 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2008
CompletedFirst Posted
Study publicly available on registry
January 16, 2008
CompletedStudy Start
First participant enrolled
February 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedJanuary 16, 2008
December 1, 2007
2 years
January 7, 2008
January 15, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
On the 3rd and 7th postoperative day, patients will judge their symptoms on that day, using VAS.
Day 3 and 7
Secondary Outcomes (1)
The patient should record painkillers needed on a daily basis for 7 days and will be provided with an EQ-5D health questionnaire.
7 days
Study Arms (2)
1
ACTIVE COMPARATORNasal Sterimar spray
2
ACTIVE COMPARATORNasal saline spray
Interventions
Post-op nasal spray, three times a day
post op nasal saline spray in syringe, three times a day
Eligibility Criteria
You may qualify if:
- Patients undergoing septoplasty and septoplasty in conjuction with turbinate surgery will be recruited.
You may not qualify if:
- Those undergoing additional procedures including polypectomy will be excluded, as will all patients whose post-operative recommendations are for steroids or other take home medications that may bias results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Grampianlead
Study Sites (1)
Department of Otorhinolaryngology, Aberdeen Royal Infirmary
Aberdeen, Scotland, AB25 2ZN, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kim W Ah-See, MD, FRCS
NHS Grampian
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
January 7, 2008
First Posted
January 16, 2008
Study Start
February 1, 2008
Primary Completion
February 1, 2010
Study Completion
February 1, 2010
Last Updated
January 16, 2008
Record last verified: 2007-12